COREY S GOODMAN
CIK 1278411 · Senior Vice President · last filed 2026-02-04
COREY S GOODMAN is a Senior Vice President who has filed 45 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing shows the insider bought $5.0M of ALXO on Feb 4, 2026. Across all open-market trades the lifetime net is +$38.8M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.36M
7
45
$38.83M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALXO | Director | 113,287 | $1.58 | $179.0K | $21.15M | 9 | 2026-02-04 |
| Ventyx Biosciences, Inc. (VTYX) Delisted | 10%+ Owner | — | $13.99 | — | $0 | 1 | 2022-06-10 |
| Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | 10%+ Owner | 2,514,415 | $10.50 | $26.40M | -$14.36M | 2 | 2022-05-09 |
| IPI Legacy Liquidation Co (IMPL) Delisted | 10%+ Owner | 2,309,791 | $0.24 | $556.9K | $33.75M | 1 | 2021-04-29 |
| Akero Therapeutics, Inc. (AKRO) Delisted | 10%+ Owner | 3,940,534 | $54.65 | $215.35M | -$1.72M | 1 | 2020-01-03 |
| PFE | Senior Vice President | 83,327 | $26.21 | $2.18M | $0 | 27 | 2009-05-01 |
| RENOVIS INC (RNVS) Delisted | President and CEO | 558,218 | — | — | $0 | 3 | 2008-02-12 |
Recent Filings
45 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-04 | ALXO | Buy (P) | +3,184,713 | $5.00M | EDGAR |
| 2026-01-21 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2025-01-23 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2023-06-22 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-09 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Sell (S) | −433,385 | -$4.49M | EDGAR |
| 2022-04-29 | Checkmate Pharmaceuticals, Inc. (CMPI) Delisted | Sell (S) | −950,130 | -$9.86M | EDGAR |
| 2021-06-15 | ALXO | Grant (A) | — | $0 | EDGAR |